Characterization of a mouse model of hyperglycemia and retinal neovascularization.

One of the limitations of research into diabetic retinopathy is the lack of suitable animal models. To study how the two important factors--hyperglycemia and vascular endothelial growth factor--interact in diabetic retinopathy, the Akimba mouse (Ins2AkitaVEGF+/-) was generated by crossing the Akita mouse (Ins2Akita) with the Kimba mouse (VEGF+/+). C57Bl/6 and the parental and Akimba mouse lines were characterized by biometric measurements, histology, immunohistochemistry, and Spectralis Heidelberg retinal angiography and optical coherence tomography. The Akimba line not only retained the characteristics of the parental strains, such as developing hyperglycemia and retinal neovascularization, but developed higher blood glucose levels at a younger age and had worse kidney-body weight ratios than the Akita line. With aging, the Akimba line demonstrated enhanced photoreceptor cell loss, thinning of the retina, and more severe retinal vascular pathology, including more severe capillary nonperfusion, vessel constriction, beading, neovascularization, fibroses, and edema, compared with the Kimba line. The vascular changes were associated with major histocompatibility complex class II+ cellular staining throughout the retina. Together, these observations suggest that hyperglycemia resulted in higher prevalences of edema and exacerbated the vascular endothelial growth factor-driven neovascular and retinal changes in the Akimba line. Thus, the Akimba line could become a useful model for studying the interplay between hyperglycemia and vascular endothelial growth factor and for testing treatment strategies for potentially blinding complications, such as edema.

[1]  E. Rakoczy,et al.  rAAV.sFlt-1 gene therapy achieves lasting reversal of retinal neovascularization in the absence of a strong immune response to the viral vector. , 2009, Investigative Ophthalmology and Visual Science.

[2]  M. Matsumura,et al.  Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy. , 2008, Ophthalmology.

[3]  X. Mu,et al.  The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis , 2008, Nature Medicine.

[4]  D. Wasserman,et al.  Markers of glycemic control in the mouse: comparisons of 6-h- and overnight-fasted blood glucoses to Hb A1c. , 2008, American journal of physiology. Endocrinology and metabolism.

[5]  A. Cavallerano,et al.  Macular thickness and systemic markers for diabetes in individuals with no or mild diabetic retinopathy , 2008, Clinical & experimental ophthalmology.

[6]  Allen R Kunselman,et al.  Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2 Akita diabetic mice. , 2008, Investigative ophthalmology & visual science.

[7]  J. Bottomley,et al.  Economic costs of diabetes in the US in 2007 — Implications for Europe , 2008 .

[8]  E. Kılıç,et al.  Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways , 2008, Clinical Neurophysiology.

[9]  J. Forrester,et al.  Identification of novel dendritic cell populations in normal mouse retina. , 2007, Investigative ophthalmology & visual science.

[10]  F. Verbraak,et al.  Decreased optical coherence tomography-measured pericentral retinal thickness in patients with diabetes mellitus type 1 with minimal diabetic retinopathy , 2007, British Journal of Ophthalmology.

[11]  E. Rakoczy,et al.  Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization. , 2006, Investigative ophthalmology & visual science.

[12]  D. Guidolin,et al.  Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model , 2006, Diabetologia.

[13]  A. Rothova,et al.  Rapid progression of diabetic retinopathy in eyes with posterior uveitis. , 2006, American journal of ophthalmology.

[14]  I. Constable,et al.  Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  W. Shen,et al.  Generation of transgenic mice with mild and severe retinal neovascularisation , 2005, British Journal of Ophthalmology.

[16]  T. Gardner,et al.  The Ins2Akita mouse as a model of early retinal complications in diabetes. , 2005, Investigative ophthalmology & visual science.

[17]  J. Jośko,et al.  Review article The neuroprotective function of vascular endothelial growth factor (VEGF) , 2005 .

[18]  I. Constable,et al.  Practical considerations of recombinant adeno‐associated virus‐mediated gene transfer for treatment of retinal degenerations , 2003, The journal of gene medicine.

[19]  K. Yamashiro,et al.  VEGF164 is proinflammatory in the diabetic retina. , 2003, Investigative ophthalmology & visual science.

[20]  P. Hogan,et al.  Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.

[21]  P. Halban,et al.  Dominant negative pathogenesis by mutant proinsulin in the Akita diabetic mouse. , 2003, Diabetes.

[22]  A. Adamis,et al.  Is diabetic retinopathy an inflammatory disease? , 2002, The British journal of ophthalmology.

[23]  Masataka Mori,et al.  Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. , 2002, The Journal of clinical investigation.

[24]  D. Wedekind,et al.  The LEW.1AR1/Ztm-iddm rat: a new model of spontaneous insulin-dependent diabetes mellitus , 2001, Diabetologia.

[25]  P. Campochiaro,et al.  Pigment epithelium‐derived factor inhibits retinal and choroidal neovascularization , 2001, Journal of cellular physiology.

[26]  E. Sutter,et al.  Assessment of early retinal changes in diabetes using a new multifocal ERG protocol , 2001, The British journal of ophthalmology.

[27]  P. Campochiaro,et al.  Retinal and choroidal neovascularization , 2000, Journal of cellular physiology.

[28]  L. Aiello,et al.  Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  K Miyamoto,et al.  VEGF increases retinal vascular ICAM-1 expression in vivo. , 1999, Investigative ophthalmology & visual science.

[30]  V. Perry.  A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation , 1998, Journal of Neuroimmunology.

[31]  I. Constable,et al.  Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularisation in the rat , 1998, The British journal of ophthalmology.

[32]  R K Jain,et al.  Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. , 1998, The Journal of investigative dermatology.

[33]  D. Foreman,et al.  VEGF localisation in diabetic retinopathy , 1998, The British journal of ophthalmology.

[34]  J. Provis,et al.  Modulation of major histocompatibility complex class II expression in retinas with age-related macular degeneration. , 1997, Investigative ophthalmology & visual science.

[35]  P. Campochiaro,et al.  Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. , 1997, The American journal of pathology.

[36]  Joan W. Miller,et al.  Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. , 1996, Ophthalmology.

[37]  G. Lutty,et al.  Localization of vascular endothelial growth factor in human retina and choroid. , 1996, Archives of ophthalmology.

[38]  R. Folberg,et al.  Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. , 1996, The British journal of ophthalmology.

[39]  A Mathis,et al.  Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. , 1994, Archives of ophthalmology.

[40]  F L Ferris,et al.  Macular edema. A complication of diabetic retinopathy. , 1984, Survey of ophthalmology.

[41]  A E Leure-duPree,et al.  Electron-opaque inclusions in the rat retinal pigment epithelium after treatment with chelators of zinc. , 1981, Investigative ophthalmology & visual science.

[42]  M. Dessouky,et al.  Inherited, Early Onset, Insulin-requiring Diabetes Mellitus of Keeshond Dogs , 1980, Diabetes.

[43]  C. Brown,et al.  Spontaneous diabetes mellitus in the New Zealand white rabbit: history, classification, and genetic analysis. , 1980, The Journal of heredity.

[44]  Y. Tochino,et al.  Breeding of a non-obese, diabetic strain of mice. , 1980, Jikken dobutsu. Experimental animals.

[45]  F. Koerner,et al.  Diabetic retinopathy study. Preliminary results from 215 patients treated uniocularly with photocoagulation. , 1977, Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. Albrecht von Graefe's archive for clinical and experimental ophthalmology.

[46]  E. Marliss,et al.  The Spontaneously Diabetic Wistar Rat: Metabolic and Morphologic Studies , 1977, Diabetes.

[47]  D. Grahn,et al.  Sex ratio of mice as possible indicator of mutation rate for sex-linked lethals. , 1967, The Journal of heredity.

[48]  G. Gerritsen,et al.  Characterization of diabetes in the Chinese hamster , 1967, Diabetologia.

[49]  J. Jośko,et al.  The neuroprotective function of vascular endothelial growth factor (VEGF). , 2005, Folia neuropathologica.

[50]  K. Miyarnoto.  Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition , 1999 .

[51]  Danhong Lu,et al.  A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. , 1999, The Journal of clinical investigation.

[52]  D. Eliott,et al.  Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. , 1997, Investigative ophthalmology & visual science.

[53]  Y. Hata,et al.  Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. , 1995, Ophthalmic research.

[54]  Diabetic retinopathy study. Report Number 6. Design, methods, and baseline results. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy. , 1981, Investigative ophthalmology & visual science.

[55]  H. Hammes,et al.  Cellular Physiology Cellular Physiology Cellular Physiology Cellular Physiology Cellular Physiology and Biochemistr and Biochemistr and Biochemistr and Biochemistr and Biochemistryyyyy , 2022 .